EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

1-Methylnicotinamide (1-MNA) inhibits the activation of the NLRP3 inflammasome in human macrophages

Karolina Sidor, Aldona Jeznach, Grażyna Hoser, Tomasz Skirecki

International Immunopharmacology · 2023

DOI: 10.1016/j.intimp.2023.110445 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Karolina Sidor und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Immunology and Experimental Intensive Care, Centre of Postgraduate Medical Education, Warsaw, Poland. Hauptthemen laut MEDLINE: Inflammasomes, NLR Family, Pyrin Domain-Containing 3 Protein. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Narodowe Centrum Nauki.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The NLRP3 inflammasome is among the most potent intracellular sensors of danger and disturbances of cellular homeostasis that can lead to the release of IL-1β and cell death, or pyroptosis. Despite its protective role, this mechanism is involved in the pathogenesis of numerous inflammatory diseases; therefore, it is seen as a potential therapeutic target. 1-methylnicotinamide (1-MNA) is a direct metabolite of nicotinamide and was previously shown to display several immunomodulatory properties, including a reduction in the reactive oxygen species (ROS). Here, we investigated whether 1-MNA could influence the activation of the NLRP3 inflammasome in human macrophages. In differentiated human macrophages we observed that 1-MNA specifically reduced the activation of the NLRP3 inflammasome. This effect was related to the scavenging of ROS, as exogenous H2O2 was able to restore NLRP3 activation. Additionally, 1-MNA increased the mitochondrial membrane potential, indicating that it did not inhibit oxidative phosphorylation. Moreover, at high but not low concentrations, 1-MNA decreased NF-κB activation and the level of pro-IL-1β. Interestingly, 1-MNA did not reduce the secretion of IL-6 upon endotoxin stimulation, confirming that its primary immunomodulatory effect on human macrophages is dependent on the NLRP3 inflammasome. Taken together, we have shown for the first time that 1-MNA reduced the activation of the NLRP3 inflammasome in human macrophages via an ROS-dependent pathway. Our results indicate a novel potential use of 1-MNA in NLRP3-related disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinHumansReactive Oxygen SpeciesHydrogen PeroxideMacrophagesNiacinamideInterleukin-1betaCaspase 1

Stichwörter der Autor:innen

InflammasomeInflammationInnate immunityPattern-recognition receptorsReactive oxygen species

Substanzen

InflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinN(1)-methylnicotinamideReactive Oxygen SpeciesHydrogen PeroxideNiacinamideInterleukin-1betaCaspase 1

Autor:innen und Institutionen

  • Department of Translational Immunology and Experimental Intensive Care, Centre of Postgraduate Medical Education, Warsaw, Poland.
  • Department of Translational Immunology and Experimental Intensive Care, Centre of Postgraduate Medical Education, Warsaw, Poland. Electronic address: tskirecki@cmkp.edu.pl.

Förderung

  • Narodowe Centrum Nauki

Zitieren

APA

Sidor, K., Jeznach, A., Hoser, G., & Skirecki, T. (2023). 1-Methylnicotinamide (1-MNA) inhibits the activation of the NLRP3 inflammasome in human macrophages. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110445

Vancouver

Sidor K, Jeznach A, Hoser G, Skirecki T. 1-Methylnicotinamide (1-MNA) inhibits the activation of the NLRP3 inflammasome in human macrophages. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110445

BibTeX
@article{Sidor2023,
  author = {Sidor, Karolina and Jeznach, Aldona and Hoser, Grażyna and Skirecki, Tomasz},
  title = {1-Methylnicotinamide (1-MNA) inhibits the activation of the NLRP3 inflammasome in human macrophages},
  journal = {International Immunopharmacology},
  year = {2023},
  doi = {10.1016/j.intimp.2023.110445}
}
Kostenlos starten →